February 20, 2009 (Ann Arbor, Michigan) — A new secretory phospholipase A 2 enzyme (sPLA 2) inhibitor, varespladib (Anthera Pharmaceuticals), has shown promise in a phase 2 trial in patients with ...
Researchers at Karolinska Institutet and Lund University in Sweden have identified a new treatment strategy for neuroblastoma, an aggressive form of childhood cancer. By combining two antioxidant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results